Purchase Order FA523625P3070

Award Date 7/15/25
Potential Completion Date 10/15/25
Potential Value $117K
Funding Federal Agency
Chief of Naval Operations
Contracting Federal Agency
Air Force Materiel Command
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Thailand
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency, a defense agency, to Bio-Active Company LIMITED, a for-profit limited liability company based in Thailand. The contract is for the acquisition of MISEQI100PLUS systems on behalf of the Armed Forces Research Institute of Medical Sciences (AFRIMS) Thailand. The contract has a ceiling value of $174,099.88 and an ultimate completion date of November 30, 2025. No small business set-aside was used for this...
This is a firm fixed price purchase order awarded by the U.S. Department of Defense's Bureau of Medicine and Surgery (BUMED) to Bio-Active Company Limited, a for-profit limited liability company based in Thailand. The contract, valued at $81,605.50, is for preventive maintenance services on an Illumina MiSeq genetic sequencing system located at the U.S. Naval Medical Research Unit-2 (NAMRU-2) facility in Cambodia. The contract was competitively awarded and does not have a set-aside...
This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Bio-Active Company LIMITED, a for-profit limited liability company based in Thailand. The $102,468 contract is for preventive maintenance services on an Illumina MiSeq genetic sequencing system operated by the Naval Medical Research Unit 2 (NAMRU-2) laboratory in Cambodia. The contract has a completion date of March 7, 2020 and was awarded on March 3, 2017. No set-aside provisions were...
This is a firm fixed price purchase order awarded by the Department of Defense, Bureau of Medicine and Surgery, to Bio-Active Company LIMITED, a for-profit limited liability company in Thailand. The $96,091.00 contract is for preventive maintenance on an Illumina MiSeq genetic sequencing system. This purchase order is not associated with a larger contract vehicle, and no set-aside designation was used. Based on Bio-Active Company LIMITED's past awards for biomedical goods and services to support...
This is a firm-fixed-price purchase order awarded by the Defense Health Agency, a component of the U.S. Department of Defense, to Bio-Active Company LIMITED, a for-profit limited liability company located in Thailand. The $112,739.29 contract is for the purchase of an Illumina MiSeq genetic sequencing system, including reagents and associated components. This award is not associated with a larger contract vehicle, and no small business set-aside provisions were used. Bio-Active Company LIMITED...
This is a firm fixed-price purchase order awarded by the U.S. Department of the Army to Bio-Active Company LIMITED, a for-profit limited liability company based in Thailand. The contract is for the procurement of Illumina sequencing platforms, including MiSeq and NextSeq systems, to be used for DNA and RNA sequencing of clinical, environmental, and vector-borne disease samples. The award has a ceiling value of $223,391.17 and an ultimate completion date of September 7, 2026. Bio-Active Company...
This is a firm fixed price purchase order awarded by the Chief of Naval Operations (CNO), a Defense agency, to Bio-Active Company LIMITED, a for-profit limited liability company. The contract is to provide Illumina sequencing systems, reagents, and testing materials to support infectious disease monitoring and research conducted by the U.S. government in Thailand. The total ceiling value of the purchase order is $35,043.75, and the period of performance runs through May 2, 2023. This award...
This is a firm fixed price blanket purchase agreement (BPA) call awarded by the Department of the Army to Bio-Active Company LIMITED, a for-profit limited liability company, to provide annual maintenance services for laboratory equipment on behalf of the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Thailand. The contract has a ceiling value of $38,595.47 and a period of performance through November 15, 2025. Bio-Active Company LIMITED has a history of providing biomedical...
This is a firm fixed price contract awarded by the Office of the Secretary of Defense to Bio-Active Company LIMITED, a for-profit limited liability company, to provide maintenance and emergency services for an Illumina MiSeq genetic sequencing instrument located in Thailand. The contract, valued at $29,088.00, is a call against a pre-existing Blanket Purchase Agreement to support infectious disease monitoring and research efforts by various U.S. government agencies, including the Centers for...
The Defense Intelligence Agency awarded a firm fixed price purchase order for $29,116 to Bio-Active Company LIMITED to provide maintenance support for one Illumina MiSeq next generation sequencing system located in Thailand. The order was issued against a blanket purchase agreement held by Bio-Active Company LIMITED to provide sequencing services and instrument sustainment to multiple U.S. agencies in Thailand, including the Department of Defense, Army Medical Command, and Centers for Disease...

This firm fixed-price purchase order, valued at $116,870.00, was awarded to Bio-Active Company LIMITED, a for-profit limited liability company based in Thailand. The contract requires the vendor to provide medical equipment and reagents to the Armed Forces Research Institute of Medical Sciences (AFRIMS), which is associated with the U.S. Department of the Navy. The contract has an ultimate completion date of October 15, 2025. Bio-Active Company LIMITED is an experienced provider of genetic sequencing systems, reagents, and testing materials to various U.S. government health organizations, with a focus on supporting infectious disease monitoring and research programs. The company holds a significant Blanket Purchase Agreement (BPA) with the U.S. Department of Defense's Medical Command (MEDCOM) to provide maintenance, emergency, and operational services for Illumina MiSeq genetic sequencing systems, which supports ongoing infectious disease surveillance activities managed by civilian and defense agencies in Thailand. No small business set-aside provisions were applied to this contract award.

Generated 10/7/25, 10:00 AM